問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2009-01-01 - 2011-12-31
Condition/Disease
Test Drug
Participate Sites3Sites
Terminated3Sites
2016-01-01 - 2023-08-01
Hepatocellular Carcinoma (HCC)
Tirapazamine
Participate Sites4Sites
Not yet recruiting4Sites
2014-05-01 - 2016-01-01
Participate Sites6Sites
Terminated6Sites
2025-10-01 - 2027-10-01
Participate Sites10Sites
Recruiting10Sites
2025-01-01 - 2026-12-31
Participate Sites2Sites
Recruiting2Sites
2025-06-02 - 2027-12-31
2018-08-01 - 2025-12-31
2021-02-01 - 2025-02-12
Participate Sites1Sites
Terminated1Sites
2023-12-01 - 2029-04-30
Participate Sites9Sites
Recruiting9Sites
2022-01-01 - 2024-07-31
Locally Advanced or Metastatic Unresectable Urothelial Cancer
Sacituzumab Govitecan
Participate Sites11Sites
Recruiting11Sites
全部
